Shingrix and Zostavax: A Compare and Contrast Quiz
Take our 5-question quiz to see what you know about these 2 vaccines, the similarities and differences, and how to accommodate both, for now. (Source: ConsultantLive)
Source: ConsultantLive - March 8, 2018 Category: Internal Medicine Authors: Terry Brenneman, MD Tags: Immunization Quiz Vaccines Source Type: news

Why the latest shingles vaccine is more than 90 percent effective
(Westmead Institute for Medical Research) A new study has shown how the body's immune system responds to the new shingles vaccine, Shingrix, making it more than 90 percent effective at protecting against the virus. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 6, 2018 Category: International Medicine & Public Health Source Type: news

ACIP Recommended Immunization Schedule for Adults: 2018 ACIP Recommended Immunization Schedule for Adults: 2018
Review the changes in the 2018 immunization schedules for adults, including guidance on the new herpes zoster vaccine, as recommended by the ACIP.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2018 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Recommendations of the ACIP for Use of Herpes Zoster Vaccines Recommendations of the ACIP for Use of Herpes Zoster Vaccines
This report updates recommendations for herpes zoster vaccine in light of the newly approved recombinant Zoster Vaccine, Shingrix.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2018 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Shingrix: Is the Hype Justified? Shingrix: Is the Hype Justified?
Dr Paul Offit compares Shingrix with Zostavax ® and lays out the recommendations for the new vaccine.Medscape Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 13, 2018 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

New Shingles Vaccine: What You Need To Know
The new vaccine is more than 90% effective at preventing shingles and a painful complication called postherpetic neuralgia (PHN) in all age groups. (Source: WebMD Health)
Source: WebMD Health - February 12, 2018 Category: Consumer Health News Source Type: news

Chicken pox vaccine linked with shingles at the vaccination site in some children
(Wiley) New research in Pediatric Dermatology reports several cases of shingles that developed at the original vaccination site in healthy children after they were immunized against chicken pox. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 9, 2018 Category: International Medicine & Public Health Source Type: news

Long-term Effectiveness of the Live Zoster Vaccine Long-term Effectiveness of the Live Zoster Vaccine
A live attenuated zoster vaccine for the prevention of shingles has been licensed for older adults in the US since 2006. How effective has it been over the long-term, and does efficacy differ by age?American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 7, 2018 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

2018 Adult ACIP Schedule Highlights New Shingles Vaccine 2018 Adult ACIP Schedule Highlights New Shingles Vaccine
The new recommendations also address the use of an extra dose of measles, mumps, and rubella vaccine during mumps outbreaks.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2018 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

ACIP Issues Updated Adult Vax Schedule
(MedPage Today) -- Changes to shingles, MMR vaccine recommendations (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 5, 2018 Category: American Health Source Type: news

CHMP Backs Shingles Vaccine Shingrix for Adults 50 and Older CHMP Backs Shingles Vaccine Shingrix for Adults 50 and Older
The European Medicines Agency ' s CHMP voted to grant marketing authorization for the Shingrix vaccine to prevent herpes zoster and postherpetic neuralgia.International Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 26, 2018 Category: Internal Medicine Tags: Infectious Diseases News Alert Source Type: news

GSK's shingles vaccine gets green light from EMA panel
(Reuters) - GlaxoSmithKline's shingles vaccine moved one step closer to market after a European Medicines Agency (EMA) panel on Friday gave a positive opinion on the drug, which is a key product for the British drugmaker's pipeline. (Source: Reuters: Health)
Source: Reuters: Health - January 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 25, 2018 Category: American Health Source Type: news

Shingles and Shingles Vaccine: An Update Shingles and Shingles Vaccine: An Update
A recently approved shingles vaccine seems to be more effective in preventing the virus. Drs Rapuano and Meghpara from Wills Eye Hospital discuss its role for patients.Wills Eye Hospital (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - January 5, 2018 Category: Opthalmology Tags: Ophthalmology Commentary Source Type: news

New Shingles Vaccine Is Cost Effective
Shingrix provides 90 percent protection and is given in two shots at $140 each. It is recommended for people 50 and older. (Source: NYT Health)
Source: NYT Health - January 4, 2018 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Shingles (Disease) Vaccination and Immunization Elderly Health Insurance and Managed Care Chicken Pox Source Type: news